// App-Quantinova.ai

BSH19‐PO‐056 : A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK

Researchers

Presenter

  • C. Harrison

Principal Investigators

  • A.J. Mead

  • M.W. Drummond

  • G. Chiu

  • R. Bains

Medical Centers

  • Department of Neurology Guy's and St. Thomas' NHS Foundation Trust, London, UK,

  • MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  • Beatson Cancer Centre and University of Glasgow, Glasgow

  • Novartis Oncology, Novartis Pharmaceuticals UK Limited, Surrey, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelofibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved